Metlife (MET) Cash & Equivalents (2009 - 2026)

Metlife's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $11.2 billion for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 0.88% year-over-year to $11.2 billion; the TTM figure through Mar 2026 stood at $11.2 billion (down 0.88% YoY), while the FY2025 annual figure was $22.0 billion, up 85.14% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $11.2 billion, down from $22.0 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $23.5 billion in Q1 2022, with the low at $1.3 billion in Q4 2022.
• The 5-year median for Cash & Equivalents is $12.0 billion (2024), against an average of $13.5 billion.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents sank 60.83% in 2023, then surged 293.91% in 2024.
• Metlife's Cash & Equivalents stood at $1.3 billion in 2022, then surged by 134.19% to $3.0 billion in 2023, then soared by 293.91% to $11.9 billion in 2024, then surged by 85.14% to $22.0 billion in 2025, then slumped by 49.16% to $11.2 billion in 2026.
• Business Quant data shows MET's Cash & Equivalents at $11.2 billion in Q1 2026, $22.0 billion in Q4 2025, and $20.2 billion in Q3 2025.